Table 2.
Treatment effects | Effect size | 95% CI | Treatment arms |
---|---|---|---|
Apoptosis inhibition | 3.09 | 1.94–4.25 | 13 |
Immunomodulation | 1.47 | 0.34–2.61 | 13 |
Growth factors (BDNF) | 1.37 | 0.57–2.17 | 14 |
Growth factors (VEGF) | 1.15 | 0.47–1.84 | 13 |
Angiogenesis | 1.18 | 0.42–1.94 | 11 |
Neurogenesis | 1.23 | 0.40–2.07 | 13 |
Gliosis reduction | 2.35 | 0.22–4.49 | 5 |
White matter function | 1.00 | 0.40–1.61 | 3 |
Enzyme supplementation | 0.81 | −0.36–1.97 | 6 |
Axonal function | 2.47 | 1.36–3.57 | 1 |